Although the mutational landscape in CRC is well known, differences in the frequency of mutations related to ethnicity have been reported; a higher frequency of mutations in PIK3CA, MAP2K1, and NF1 have been seen in tumor samples from patients of African American ethnicity compared to Caucasians [9]. The gene discussed is PIK3CA; the disease is neoplasm.